临床肿瘤学杂志

• 综述与讲座 • 上一篇    下一篇

奥氮平防治化疗相关性呕吐的研究进展

周冬爱1,易 俊2 综述, 马进安1 审校
  

  1. 1 410011 长沙 中南大学湘雅二医院肿瘤科2 410011 中南大学湘雅二医院消化内科
  • 收稿日期:2014-09-24 修回日期:2015-02-01 出版日期:2015-06-30 发布日期:2015-06-30
  • 通讯作者: 马进安

Progression on prevention and treatment of olanzapine in chemotherapyinduced nausea and vomiting

ZHOU Dongai,YI Jun,MA Jin'an.
  

  1. Department of Oncology, the Second Xiangya Hospital of Central South University, Changsha 410011, China
  • Received:2014-09-24 Revised:2015-02-01 Online:2015-06-30 Published:2015-06-30
  • Contact: MA Jin'an

摘要: 化疗所致的恶心呕吐(CINV)是化疗最常见的消化道副作用,也是影响患者化疗依从性的重要原因之一。奥氮平作为一种在精神科已被临床广泛应用的非典型抗精神病药物,具有拮抗多种呕吐相关受体作用,近年被越来越多的研究证实可有效地防治化疗所致的恶心呕吐,且不良反应轻微,耐受性良好。本文综述了近年奥氮平防治CINV的临床研究进展。

Abstract: Chemotherapyinduced nausea and vomiting is the most common gastrointestinal reaction of chemotherapy side effects, and also one of the important influential factors in chemotherapy compliance within tumor patients. Olanzapine is a widely-used atypical antipsychotics in psychiatric clinical pratice, which also has a ability to block many different antiemetic properties ossociated receptors. In recent years, olanzapine has been approved effectively in the prevention and treatment of chemotherapyinduced nausea and vomiting, with little adverse reaction and good tolerance. This paper summarizes the clnical progression on prevention and treatment of olanzapine in chemotherapy induced nausea and vomiting.

No related articles found!
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!